&w=1200&resize=1200,900&ssl=1 "Alembic Pharma gets US health regulator FDA’s nod for scalp psoriasis treatment drug")
Alembic Pharmaceuticals said it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Betamethasone Valerate Foam. The approved ANDA is therapeutically equivalent to the reference listed drug product Luxiq Foam (0.12 per cent), of Norvium Bioscience, LLC (Norvium). | Representational image | Image credit:…
&w=1200&resize=1200,900&ssl=1&description=Alembic%20Pharma%20gets%20US%20health%20regulator%20FDA%E2%80%99s%20nod%20for%20scalp%20psoriasis%20treatment%20drug){kind=link}